APLM - Apollomic Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

2.101B

Cash

54.62M

Avg Qtr Burn

-10.71M

Short % of Float

0.00%

Insider Ownership

80.33%

Institutional Own.

Qtr Updated

12/31/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
APL-106 Details Acute myeloid leukemia	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
APL-101 Details Glioblastoma, Non-small cell lung carcinoma	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.